Aims Treatment guidelines for atypical femoral fractures associated with bisphosphonates
have not been established. We conducted a systematic review of the treatment of atypical …

Bisphosphonates are commonly used in osteoporosis, but concerns have been raised about
possible negative effects on fracture healing. We systematically reviewed the literature and …

Background Bisphosphonate therapy for osteoporosis has been associated with atypical
femoral fractures. To date, there have been few reports in the literature regarding the …

Background: The purpose of this study was to analyze factors that affect healing time after
operative treatment of complete femoral fractures associated with long-term use of …

Objectives: The purpose of this study was to characterize demographics, healing time, and
complications of a large series of operatively treated atypical femur fractures. Design …

Background Atypical femoral fractures (AFF) are a rare type of femoral stress fracture
recently described, potentially associated with prolonged bisphosphonate therapy. Evidence …

Objective: To describe the outcomes for patients treated at a single institution, who sustained
incomplete bisphosphonate-induced femoral fractures. Design: Retrospective review …

Atypical femur fractures associated with long-term bisphosphonate use can be challenging
injuries to manage. Not only do they have a prolonged healing time and increased rate of …

Atypical femoral fractures are often attributed to the use of anti-resorptive medications such
as bisphosphonates (BP). Whilst they have proven effects on fragility fracture prevention …

Background Bisphosphonates decrease the risk of typical low trauma fractures, and are
commonly prescribed for this indication. The link between atypical fractures and …